Jianjun Ye
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
The efficacy and safety of disitamab vedotin plus immunotherapy in locally advanced or metastatic solid tumors: a systematic review and meta-analysis.
Journal: Frontiers in immunology
Published: December 09, 2025
Efficacy of disitamab vedotin-based therapy in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis.
Journal: Urologic oncology
Published: October 19, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 27, 2025
Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing Strategy.
Journal: European urology oncology
Published: February 03, 2025
Optimizing the strategies to perform prostate biopsy in MRI-positive patients: a systematic review and network meta-analysis.
Journal: EClinicalMedicine
Published: November 20, 2024
Creatinine-Cystatin C Ratio as a Promising Prognostic Biomarker in Patients With UTUC After Radical Nephroureterectomy.
Journal: Clinical genitourinary cancer
Published: November 08, 2024
Geriatric Nutritional Risk Index as a prognostic marker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy.
Journal: Scientific reports
Published: October 29, 2024
Frailty, high-sensitivity C-reactive protein and cardiovascular disease: a nationwide prospective cohort study.
Journal: Aging clinical and experimental research
Published: October 07, 2024
The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-naïve Men.
Journal: European urology open science
Published: April 10, 2024
Is ipsilateral systematic biopsy combined with targeted biopsy the optimal substitute for bilateral systematic biopsy combined with targeted biopsy: A systematic review and meta-analysis.
Journal: Urologic oncology
Published: April 03, 2024
Last Updated: 09/26/2026